1. Home
  2. ALLR vs SGLY Comparison

ALLR vs SGLY Comparison

Compare ALLR & SGLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLR
  • SGLY
  • Stock Information
  • Founded
  • ALLR 2004
  • SGLY 2001
  • Country
  • ALLR United States
  • SGLY United States
  • Employees
  • ALLR N/A
  • SGLY N/A
  • Industry
  • ALLR Biotechnology: Pharmaceutical Preparations
  • SGLY
  • Sector
  • ALLR Health Care
  • SGLY
  • Exchange
  • ALLR Nasdaq
  • SGLY Nasdaq
  • Market Cap
  • ALLR 13.3M
  • SGLY 3.9M
  • IPO Year
  • ALLR N/A
  • SGLY 2008
  • Fundamental
  • Price
  • ALLR $0.90
  • SGLY $1.05
  • Analyst Decision
  • ALLR
  • SGLY
  • Analyst Count
  • ALLR 0
  • SGLY 0
  • Target Price
  • ALLR N/A
  • SGLY N/A
  • AVG Volume (30 Days)
  • ALLR 453.6K
  • SGLY 420.0K
  • Earning Date
  • ALLR 08-04-2025
  • SGLY 05-15-2025
  • Dividend Yield
  • ALLR N/A
  • SGLY N/A
  • EPS Growth
  • ALLR N/A
  • SGLY N/A
  • EPS
  • ALLR N/A
  • SGLY N/A
  • Revenue
  • ALLR N/A
  • SGLY $2,172,036.00
  • Revenue This Year
  • ALLR N/A
  • SGLY N/A
  • Revenue Next Year
  • ALLR N/A
  • SGLY N/A
  • P/E Ratio
  • ALLR N/A
  • SGLY N/A
  • Revenue Growth
  • ALLR N/A
  • SGLY N/A
  • 52 Week Low
  • ALLR $0.61
  • SGLY $0.54
  • 52 Week High
  • ALLR $14.25
  • SGLY $7.65
  • Technical
  • Relative Strength Index (RSI)
  • ALLR 49.46
  • SGLY 56.58
  • Support Level
  • ALLR $0.80
  • SGLY $1.02
  • Resistance Level
  • ALLR $0.98
  • SGLY $1.16
  • Average True Range (ATR)
  • ALLR 0.06
  • SGLY 0.08
  • MACD
  • ALLR 0.01
  • SGLY 0.01
  • Stochastic Oscillator
  • ALLR 61.93
  • SGLY 73.41

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.

About SGLY Singularity Future Technology Ltd.

Singularity Future Technology Ltd is an investment holding company. The company's operating segment includes Freight Logistics Services and Sale of Crypto-mining Machines. It generates maximum revenue from the Freight Logistics Services segment. Geographically, it derives a majority of its revenue from China.

Share on Social Networks: